{"id":2878,"date":"2021-11-01T12:06:00","date_gmt":"2021-11-01T11:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2021\/leserbrief-degenerative-herzklappenerkrankung-kontraindikation-fuer-osteoporose-medikamente-indikation-fuer-statine"},"modified":"2021-11-01T12:06:00","modified_gmt":"2021-11-01T11:06:00","slug":"leserbrief-degenerative-herzklappenerkrankung-kontraindikation-fuer-osteoporose-medikamente-indikation-fuer-statine","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2021\/leserbrief-degenerative-herzklappenerkrankung-kontraindikation-fuer-osteoporose-medikamente-indikation-fuer-statine","title":{"rendered":"Leserbrief: Degenerative Herzklappenerkrankung: Kontraindikation f\u00fcr Osteoporose-Medikamente? Indikation f\u00fcr Statine?"},"content":{"rendered":"<p>Frage von J.S. aus S.: >> Eine 80-j\u00e4hrige Patientin mit Rheumatoider Arthritis erh\u00e4lt seit 18 Jahren 5 mg\/d Methylprednisolon (Urbason\u00ae). Sie ist adip\u00f6s (BMI 31 kg\/m2) und hat wegen einer H\u00fcftfraktur vor 5 Jahren eine H\u00fcft-TEP erhalten. Seit \u00fcber 10 Jahren erh\u00e4lt sie ein Bisphosphonat (Risedronat 35 mg 1x\/Woche), sowie t\u00e4glich ein Kombinationspr\u00e4parat mit Kalziumkarbonat [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von J.S. aus S.: >> Eine 80-j\u00e4hrige Patientin mit Rheumatoider Arthritis erh\u00e4lt seit 18 Jahren 5 mg\/d Methylprednisolon (Urbason\u00ae). Sie ist adip\u00f6s (BMI 31 kg\/m2) und hat wegen einer H\u00fcftfraktur vor 5 Jahren eine H\u00fcft-TEP erhalten. Seit \u00fcber 10 Jahren erh\u00e4lt sie ein Bisphosphonat (Risedronat 35 mg 1x\/Woche), sowie t\u00e4glich ein Kombinationspr\u00e4parat mit Kalziumkarbonat [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2337,2736,2678,2676,2454,145,1661,3927,840,1238,516,5584,4326,1233,636,3314,5583,680,3313,5582,443,3783],"class_list":["post-2878","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-alendronsaeure","tag-aortenklappe","tag-aortenklappen-stenose","tag-aortenstenose","tag-argatroban","tag-bisphosphonate","tag-cabergolin","tag-colesevelam","tag-denosumab","tag-ergotamin","tag-fenfluramin","tag-herzklappenverkalkungen","tag-lanreotid","tag-memantin","tag-methysergid","tag-mitralinsuffizienz","tag-mitralklappe","tag-naproxen","tag-pergolid","tag-saltire-ii-studie","tag-statine","tag-valdecoxib"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2878"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2878\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}